Clinical Trial Update: Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examines the effect of hydroxychloroquine on atrial fibrillation recurrence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN